The University of Alberta’s Mike Petrick School of Dentistry offers what it says is the only accredited neuromodulator course available to undergraduate dental students in North America.
According to the university, the course provides students with increasingly popular real-world skills.
“Programs like this provide students with valuable hands-on skills and opportunities for interprofessional collaboration,” says James Yacyshyn, director of the school’s continuing dental education program. “This provides students with an opportunity to go beyond traditional dental training and engage with medical and allied health professionals.”
Neuromodulators, such as Xeomin, Letybo, and Botox, are injected into facial muscles to temporarily relax or inhibit muscle activity. These substances are used to treat muscle-related pain, manage certain diseases, and reduce facial wrinkles.
The University of Alberta’s course includes online and pre-course materials, as well as three days of intensive hands-on training. Students first practice injections on cadavers and then perform them on live patients under supervision in a controlled clinical setting.
The training covers both therapeutic and cosmetic uses, including patient assessment, facial anatomy, injection techniques, and safe administration.
The Neuromodulators Level I/II course will be available this fall to the DDS Class of 2026. Twelve students will be admitted on a first-come, first-served basis and will receive a Neuromodulators Continuing Education Certificate upon graduation.
Related topics:
